CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
-1.37%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.2B
AUM Growth
+$2.05B
(+17%)
Cap. Flow
+$2.32B
Cap. Flow
% of AUM
16.35%
Top 10 Holdings %
Top 10 Hldgs %
24.41%
Holding
921
New
139
Increased
425
Reduced
185
Closed
46
Top Buys
| 1 |
Apple
AAPL
|
$199M |
| 2 |
Microsoft
MSFT
|
$181M |
| 3 |
Tesla
TSLA
|
$79.1M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$56.5M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$55.9M |
Top Sells
| 1 |
Sociedad Química y Minera de Chile
SQM
|
$56.4M |
| 2 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$36.9M |
| 3 |
Meta Platforms (Facebook)
META
|
$32.7M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$28.5M |
| 5 |
Booking.com
BKNG
|
$24.5M |
Sector Composition
| 1 | Healthcare | 31.76% |
| 2 | Technology | 24.47% |
| 3 | Financials | 9.64% |
| 4 | Consumer Discretionary | 7.95% |
| 5 | Industrials | 7.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
Enovis
ENOV
$1.83B
| $906K | 0.01% |
+19,667
| New | +$906K |
|
702
Encompass Health
EHC
$12.6B
| $900K | 0.01% |
+19,907
| New | +$900K |
|
703
Castle Biosciences
CSTL
$666M
| $898K | 0.01% |
+34,423
| New | +$898K |
|
704
Aclaris Therapeutics
ACRS
$227M
| $886K | 0.01% |
+56,279
| New | +$886K |
|
705
Cerus
CERS
$247M
| $885K | 0.01% |
+245,791
| New | +$885K |
|
706
Alector
ALEC
$298M
| $871K | 0.01% |
+92,113
| New | +$871K |
|
707
Goldman Sachs
GS
$220B
| $867K | 0.01% |
2,958
+69
| +2% | +$20.2K |
|
708
Codexis
CDXS
$218M
| $866K | 0.01% |
+142,953
| New | +$866K |
|
709
Howmet Aerospace
HWM
$70.5B
| $866K | 0.01% |
27,982
| – | – |
|
710
Lantheus
LNTH
$3.66B
| $863K | 0.01% |
12,277
-19,082
| -61% | -$1.34M |
|
|
NVTA
711
DELISTED
Invitae Corporation
NVTA
| $859K | 0.01% |
+349,095
| New | +$859K |
|
712
EQT Corp
EQT
$32B
| $858K | 0.01% |
21,048
-111
| -0.5% | -$4.53K |
|
713
Opko Health
OPK
$1.06B
| $855K | 0.01% |
+452,348
| New | +$855K |
|
714
Atara Biotherapeutics
ATRA
$88.5M
| $849K | 0.01% |
+8,984
| New | +$849K |
|
|
TVRD
715
Tvardi Therapeutics, Inc. Common Stock
TVRD
$284M
| $848K | 0.01% |
+2,515
| New | +$848K |
|
716
NeoGenomics
NEO
$1.04B
| $847K | 0.01% |
+98,316
| New | +$847K |
|
717
Select Medical
SEM
$1.63B
| $847K | 0.01% |
+71,161
| New | +$847K |
|
718
Henry Schein
HSIC
$8.29B
| $846K | 0.01% |
+12,868
| New | +$846K |
|
719
American Homes 4 Rent
AMH
$12.8B
| $845K | 0.01% |
+25,747
| New | +$845K |
|
720
Myriad Genetics
MYGN
$619M
| $843K | 0.01% |
+44,157
| New | +$843K |
|
|
LSXMA
721
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $838K | 0.01% |
+29,965
| New | +$838K |
|
|
COWN
722
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $834K | 0.01% |
+21,578
| New | +$834K |
|
|
BKI
723
DELISTED
Black Knight, Inc. Common Stock
BKI
| $831K | 0.01% |
+12,834
| New | +$831K |
|
724
Prelude Therapeutics
PRLD
$65.7M
| $830K | 0.01% |
+125,619
| New | +$830K |
|
725
Mesa Laboratories
MLAB
$354M
| $828K | 0.01% |
5,876
-2,221
| -27% | -$313K |
|